Phase II evaluation of thalidomide in patients with metastatic breast cancer.
Baidas SM, Winer EP, Fleming GF, Harris L, Pluda JM, Crawford JG, Yamauchi H, Isaacs C, Hanfelt J, Tefft M, Flockhart D, Johnson MD, Hawkins MJ, Lippman ME, Hayes DF.
Baidas SM, et al. Among authors: isaacs c.
J Clin Oncol. 2000 Jul;18(14):2710-7. doi: 10.1200/JCO.2000.18.14.2710.
J Clin Oncol. 2000.
PMID: 10894870
Clinical Trial.